This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Nozomu Kakimoto: Innovator in Cationic Lipid Technology
Introduction
Nozomu Kakimoto is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of cationic lipids. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Nozomu Kakimoto holds a patent for a cationic lipid, which is crucial in various pharmaceutical applications. This patent highlights his ability to create solutions that can enhance drug delivery systems and improve therapeutic outcomes. He has 1 patent to his name, reflecting his commitment to innovation in the pharmaceutical industry.
Career Highlights
Kakimoto is currently employed at Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His role at Takeda allows him to work on cutting-edge research and development projects that aim to address unmet medical needs. His contributions have been instrumental in advancing the company's mission to bring innovative medicines to patients.
Collaborations
Throughout his career, Nozomu Kakimoto has collaborated with notable colleagues, including Satoru Matsumoto and Yoshimasa Omori. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, ultimately leading to groundbreaking advancements in their respective fields.
Conclusion
Nozomu Kakimoto is a dedicated inventor whose work in cationic lipid technology has the potential to transform pharmaceutical applications. His contributions at Takeda Pharmaceutical Company Limited and his collaborations with esteemed colleagues underscore his impact on the industry. Kakimoto's innovative spirit continues to drive advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
